HCW Biologics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy HCW Biologics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for HCW Biologics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for HCW Biologics Inc. is HCWB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
HCW Biologics Inc. has its primary listing on NASDAQ. You can trade HCW Biologics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, HCW Biologics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include HCW Biologics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like HCW Biologics Inc..